Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP II
Circulation · 03.12.2024 · 150 (23) · 1837-1846
DOI: 10.1161/circulationaha.124.071176 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 03.12.2024. Verfasst von Katrin Kemp Gudmundsdottir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Karolinska Institutet, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd University Hospital, Stockholm, Sweden (K.K.G.,…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Peptide Fragments, Natriuretic Peptide, Brain, Electrocardiography. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Roche Diagnostics, Carl Bennet AB, Stockholm Region.
Abstract (Originalsprache)
BACKGROUND: Guidelines have suggested screening for atrial fibrillation to enable early treatment and avoid downstream negative clinical events. We aimed to determine whether atrial fibrillation screening potentially enhanced by NT-proBNP (N-terminal pro-B-type natriuretic peptide) would reduce stroke or systemic embolism incidence compared with a control group and to determine whether it was safe for those with low NT-proBNP concentrations to forfeit prolonged screening. METHODS: In this randomized controlled trial, all 75- and 76-year-old individuals in Stockholm Region, Sweden, were randomized 1:1 to be invited to screening or serve as a control group. NT-proBNP concentrations were measured, and a single-lead ECG was registered only once if NT-proBNP
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Karolinska Institutet, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd University Hospital, Stockholm, Sweden (K.K.G., L.F., T.H., V.F., F.A.-K., M.R., J.E.).
- Karolinska Institutet, Department of Medicine Huddinge (H7), Karolinska University Hospital Huddinge, Stockholm, Sweden (E.S.).
- Department of Medical Sciences, Cardiology, Uppsala University, Sweden (Z.H.).
ORCID-Profile: Katrin Kemp Gudmundsdottir, Emma Svennberg, Leif Friberg, Tove Hygrell, Viveka Frykman, Faris Al-Khalili, Ziad Hijazi, Mårten Rosenqvist
Förderung
- Roche Diagnostics
- Carl Bennet AB
- Stockholm Region
- Hjärt-Lungfonden
Zitieren
APA
Kemp Gudmundsdottir, K., Svennberg, E., Friberg, L., Hygrell, T., Frykman, V., Al-Khalili, F., Hijazi, Z., Rosenqvist, M., & Engdahl, J. (2024). Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP II. Circulation, 150(23), 1837-1846. https://doi.org/10.1161/circulationaha.124.071176
Vancouver
Kemp Gudmundsdottir K, Svennberg E, Friberg L, Hygrell T, Frykman V, Al-Khalili F, et al. Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP II. Circulation. 2024;150(23):1837-1846. doi:10.1161/circulationaha.124.071176
BibTeX
@article{KempGudmundsdottir2024,
author = {Kemp Gudmundsdottir, Katrin and Svennberg, Emma and Friberg, Leif and Hygrell, Tove and Frykman, Viveka and Al-Khalili, Faris and Hijazi, Ziad and Rosenqvist, Mårten and Engdahl, Johan},
title = {Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP II},
journal = {Circulation},
year = {2024},
volume = {150},
number = {23},
pages = {1837--1846},
doi = {10.1161/circulationaha.124.071176}
}
EUVIMED